RECENT NEWS

Dartford and Gravesham NHS Trust has partnered with Better and Alcidion to successfully roll out the Better Meds electronic prescribing and medicine management (EPMA) system, and integrate it into the trust’s EPR system provided by Alcidion.

The Clinical Services Journal will be hosting a panel discussion on 'De-risking Investment in Healthcare Tracking Technology', featuring leading experts from two NHS Trusts, as well as leading technology specialists from Blyott and Idox.

New Alzheimer’s studies have revealed insights into the disease biology, risk for progression, and the potential for a novel blood test.

A new Research Letter, published in Palliative Medicine, estimates that the palliative care needs of people living with dementia in England and Wales will be much higher by 2040 than previous projections have indicated.

NHS Cheshire and Merseyside and HealthTrust Europe (‘HTE’) have announced an agreement to collaborate on an ICS delivery partnership, following a detailed partner review process.

A programme of inspections by the Care Quality Commission (CQC) has found continued concerns about the quality of NHS hospital maternity services with common issues impacting on safety at services across the country.

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.

A fifth of family doctors (GPs) seem to have readily incorporated AI into their clinical practice, despite a lack of any formal guidance or clear work policies on the use of these tools, suggest the findings of an online UK-wide snapshot survey.

The UK Government has ordered more mpox vaccine doses to help boost the country’s resilience against clade I mpox, as it also continues to support the international effort to control the disease.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new three-year Strategy for Improving Safety Communications, which aims to transform the way the health service provides information about the risks and safety of medicines, medical devices and healthcare products in the UK to support effective implementation of new safety measures.

MicrosensDx has announced that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.

​A study recently published in the New England Journal of Medicine, and presented at the European Society of Cardiology Congress held from 30 August to 2 September, has demonstrated the benefits of placing a clip on the valve instead of the usual medical treatment.

A group of research nurses and computing scientists at Sheffield Teaching Hospitals NHS Foundation Trust have won the regional NHS Parliamentary Awards in recognition of an innovative tool which they have developed to ensure more patients can participate in research trials.

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group of scientists from the across the world has warned.

All health and social care employers, including NHS Trusts and health boards, must address the causes of workplace stressors in their organisations and prevent them from contributing to suicidal thoughts among nursing staff, according to a new report from the Royal College of Nursing (RCN).

The first results from six new national cancer audits have been published by the National Cancer Audit Collaborating Centre (NATCAN), commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government.

Imperial spinout Dosium is working with the NHS to roll out a clinical decision support tool that provides dosage guidance to increase patient safety.

The NHS has experienced the busiest summer ever for accident and emergency (A&E) departments in England, new figures reveal, with NHS staff managing 6.8 million attendances in three months.

Lord Ara Darzi has published a full and independent investigation into the state of the NHS and has concluded that the service is in a ‘critical condition’, but it 'can be fixed'.

The first of its kind AI study, funded by the NHS to investigate the use of predictive AI in direct care of patients, has encouraging interim primary objective analyses now available, which support that predictive AI is not only safe and effective in healthcare but also well-accepted by users.